Drug · DIN 02414716
ACT EZETIMIBE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 12, 2018; first marketed September 15, 2014.
- Drug Identification Number (DIN)
- 02414716
- Company (DIN owner)
- Actavis Pharma CompanyToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Ezetimibe C10AX09
- Class
- Human
- Record last updated
- June 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EZETIMIBE | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 15, 2014: NOC 16069Abbreviated New Drug Submission (ANDS)